We show that 2 distinct dMMR-associated mutational signatures can be robustly derived from exomes and that these signatures predominate in cancers with MMR gene mutations, and associate with higher MSINGS and previously described transcriptomic signatures of MMR-defective disease. The gene discussed is MRC1; the disease is cancer.